CHINA RESOURCES PHARMACEUTICAL GRCHINA RESOURCES PHARMACEUTICAL GRCHINA RESOURCES PHARMACEUTICAL GR

CHINA RESOURCES PHARMACEUTICAL GR

No trades
See on Supercharts

3320 fundamentals

CHINA RESOURCES PHARMACEUTICAL GR key financial stats and ratios

3320 price-to-sales ratio is 0.11. The company has an Enterprise Value to EBITDA ratio of 8.72. As of 2024 they employed 72.7 k people.

Statistics
Price to earnings ratio
Price to cash flow ratio
Currency: HKD
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios